| 【公司研究】博奇環保 (2377 HK) – 戰略性轉型初見成效 |
| 【Company Research】Haier Smart Home (6690 HK) – Solid market share gain and 2H21E outlook |
| 【Fixed Income Research】HONGQI - 9 months’ raw material inventory in Shandong to weather political turmoil in Guinea |
| 【Fixed Income Research】EHOUSE - Lower to Neutral given its remaining Evergrande exposure |
| 【Company Research】SANY International (631 HK) – Sustainable growth driven by intelligent mining products and robotic business |
| 【Company Research】FriendTimes Inc. (6820 HK) – Investing in R&D to deliver premium games |
| 【Fixed Income Research】1H2021 “Three Red Lines” Update |
| 【Company Research】Jinxin Fertility (1951 HK) – Better-than-expected recovery from COVID-19 impact |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Maintained dominant position in TAVR market |
| 【Company Research】I-Mab BioPharma (IMAB US) – Diversified and highly-differentiated pipeline |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
